Roche
ROG.SW
#36
Rank
NZ$544.46 B
Marketcap
NZ$678.66
Share price
1.48%
Change (1 day)
39.85%
Change (1 year)

Revenue for Roche (ROG.SW)

Revenue in 2024: NZ$119.36 Billion

According to Roche's latest financial reports the company's current revenue (TTM ) is NZ$119.36 Billion. In 2024 the company made a revenue of NZ$119.36 Billion a decrease over the revenue in the year 2023 that were of NZ$124.22 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Roche from 1998 to 2024

Annual revenue

Year Revenue Change
2024NZ$119.36 B-3.91%
2023NZ$124.22 B0.91%
2022NZ$123.10 B3.65%
2021NZ$118.76 B3.89%
2020NZ$114.31 B4.26%
2019NZ$109.65 B9.8%
2018NZ$99.86 B5.58%
2017NZ$94.58 B10.25%
2016NZ$85.79 B1.88%
2015NZ$84.20 B1.49%
2014NZ$82.96 B-8.94%
2013NZ$91.11 B5.76%
2012NZ$86.15 B9.97%
2011NZ$78.34 B-10.75%
2010NZ$87.78 B7.11%
2009NZ$81.95 B8.43%
2008NZ$75.58 B7.33%
2007NZ$70.42 B17.93%
2006NZ$59.71 B28.04%
2005NZ$46.63 B4.26%
2004NZ$44.72 B2.53%
2003NZ$43.62 B-31.41%
2002NZ$63.60 B0.99%
2001NZ$62.97 B1.71%
2000NZ$61.91 B4.01%
1999NZ$59.53 B11.78%
1998NZ$53.25 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
NZ$159.23 B 33.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$110.99 B-7.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$108.49 B-9.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$82.12 B-31.20%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
NZ$97.41 B-18.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
GlaxoSmithKline
GSK
NZ$73.18 B-38.69%๐Ÿ‡ฌ๐Ÿ‡ง UK
Abbott Laboratories
ABT
NZ$75.76 B-36.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$62.15 B-47.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
NZ$36.95 B-69.04%๐Ÿ‡บ๐Ÿ‡ธ USA